KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Change in Account Payables (2021 - 2025)

LifeMD's Change in Account Payables history spans 5 years, with the latest figure at -$300768.0 for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 50.41% year-over-year to -$300768.0; the TTM value through Dec 2025 reached $3.2 million, down 22.31%, while the annual FY2025 figure was $3.2 million, 22.31% down from the prior year.
  • Change in Account Payables reached -$300768.0 in Q4 2025 per LFMD's latest filing, up from -$4.7 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $8.6 million in Q2 2025 to a low of -$4.7 million in Q3 2025.
  • Average Change in Account Payables over 5 years is $447307.2, with a median of $124633.0 recorded in 2021.
  • Peak YoY movement for Change in Account Payables: soared 1887.81% in 2022, then plummeted 680.84% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at -$2.4 million in 2021, then surged by 76.07% to -$576066.0 in 2022, then soared by 351.27% to $1.4 million in 2023, then tumbled by 141.9% to -$606501.0 in 2024, then skyrocketed by 50.41% to -$300768.0 in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Change in Account Payables are -$300768.0 (Q4 2025), -$4.7 million (Q3 2025), and $8.6 million (Q2 2025).